Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Francis PA, Pagani O, Fleming GF, Walley BA, Colleoni M, Láng I, Gómez HL, Tondini C, Ciruelos E, Burstein HJ, Bonnefoi HR, Bellet M, Martino S, Geyer CE Jr, Goetz MP, Stearns V, Pinotti G, Puglisi F, Spazzapan S, Climent MA, Pavesi L, Ruhstaller T, Davidson NE, Coleman R, Debled M, Buchholz S, Ingle JN, Winer EP, Maibach R, Rabaglio-Poretti M, Ruepp B, Di Leo A, Coates AS, Gelber RD, Goldhirsch A, Regan MM; SOFT and TEXT Investigators and the International Breast Cancer Study Group. Francis PA, et al. N Engl J Med. 2018 Jul 12;379(2):122-137. doi: 10.1056/NEJMoa1803164. Epub 2018 Jun 4. N Engl J Med. 2018. PMID: 29863451 Free PMC article. Clinical Trial.
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line.
Colombo N, Gadducci A, Sehouli J, Rulli E, Mäenpää J, Sessa C, Montes A, Ottevanger NB, Berger R, Vergote I, D'Incalci M, Churruca Galaz C, Chekerov R, Nyvang GB, Riniker S, Herbertson R, Fossati R, Barretina-Ginesta MP, Deryal M, Mirza MR, Biagioli E, Iglesias M, Funari G, Romeo M, Tasca G, Pardo B, Tognon G, Rubio-Pérez MJ, DeCensi A, De Giorgi U, Zola P, Benedetti Panici P, Aglietta M, Arcangeli V, Zamagni C, Bologna A, Westermann A, Heinzelmann-Schwarz V, Tsibulak I, Wimberger P, Poveda A; INOVATYON study group. Colombo N, et al. Br J Cancer. 2023 Apr;128(8):1503-1513. doi: 10.1038/s41416-022-02108-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759720 Free PMC article. Clinical Trial.
Paclitaxel plus Eftilagimod Alpha, a Soluble LAG-3 Protein, in Metastatic, HR+ Breast Cancer: Results from AIPAC, a Randomized, Placebo Controlled Phase IIb Trial.
Wildiers H, Armstrong A, Cuypere E, Dalenc F, Dirix L, Chan S, Marme F, Schröder CP, Huober J, Duhoux FP, Vuylsteke P, Jager A, Brain E, Kuemmel S, Pápai Z, Menke-van der Houven van Oordt CW, Perjesi L, Mueller C, Brignone C, Triebel F. Wildiers H, et al. Among authors: vuylsteke p. Clin Cancer Res. 2024 Feb 1;30(3):532-541. doi: 10.1158/1078-0432.CCR-23-1173. Clin Cancer Res. 2024. PMID: 37939105 Free PMC article. Clinical Trial.
Bibliometric analysis of cancer research outputs in Botswana between 2009 and 2021.
Koobotse MO, Zachariah M, Senabye B, Gobe I, Kadimo K, Nthontho KC, Mokomane M, Koto G, Phuthego T, Lekgetho H, Ndlovu A, Motswaledi M, Mbwinja A, Tawe L, Ramatlho P, Paganotti GM, Kyokunda L, Vuylsteke P, Grover S, Ramogola-Masire D, Kasvosve I. Koobotse MO, et al. Among authors: vuylsteke p. J Cancer Policy. 2023 Mar;35:100405. doi: 10.1016/j.jcpo.2023.100405. Epub 2023 Jan 20. J Cancer Policy. 2023. PMID: 36690157 Free PMC article. Review.
Advancing oncology drug therapies for sub-Saharan Africa.
Sharma K, Mayer T, Li S, Qureshi S, Farooq F, Vuylsteke P, Ralefala T, Marlink R. Sharma K, et al. Among authors: vuylsteke p. PLOS Glob Public Health. 2023 Jun 27;3(6):e0001653. doi: 10.1371/journal.pgph.0001653. eCollection 2023. PLOS Glob Public Health. 2023. PMID: 37368872 Free PMC article. Review.
Significance of HIV status in cervical cancer patients receiving curative chemoradiation therapy, definitive radiation alone, or palliative radiation in Botswana.
Meghani K, Puri P, Bazzett-Matabele L, Vuylsteke P, Luckett R, Monare B, Chiyapo S, Ketlametswe R, Ralefala TB, Bvochora-Nsingo M, Zetola N, Ramogola-Masire D, Grover S. Meghani K, et al. Among authors: vuylsteke p. Cancer. 2024 Jul 15;130(14):2462-2471. doi: 10.1002/cncr.35289. Epub 2024 Mar 26. Cancer. 2024. PMID: 38529676
Expanding Geographical Access to Cancer Care in Botswana: Current Status and Future Prospects.
Swart NC, Lebelonyane R, Gutterman EM, Legwaila M, Friebel-Klingner TM, Antony R, Mayer T, Sharma K, Lall N, Kania B, Gaolathe T, Ralefala T, Ndaba V, Leselwa T, Vuylsteke P, Marlink R. Swart NC, et al. Among authors: vuylsteke p. JCO Glob Oncol. 2024 Sep;10:e2400196. doi: 10.1200/GO.24.00196. Epub 2024 Sep 30. JCO Glob Oncol. 2024. PMID: 39348622
Access to and Utilization of Endocrine Therapy Among Breast Cancer Survivors in Botswana.
Wester JR, Wagner RB, Motladiile B, Nkele I, Chinyepi N, Makhema MJ, Friebel-Klingner TM, Vuylsteke P, Lockman S, Dryden-Peterson S, Kohler RE. Wester JR, et al. Among authors: vuylsteke p. JCO Glob Oncol. 2024 Dec;10:e2400180. doi: 10.1200/GO.24.00180. Epub 2024 Dec 12. JCO Glob Oncol. 2024. PMID: 39666914 Free PMC article.
Treatment approaches for prostate cancer in sub-Saharan Africa.
Kania B, Sharma K, Ramatlho P, Vuylsteke P, Ndlovu A, Mayer T. Kania B, et al. Among authors: vuylsteke p. Transl Cancer Res. 2024 Nov 30;13(11):6503-6510. doi: 10.21037/tcr-23-2289. Epub 2024 Jul 16. Transl Cancer Res. 2024. PMID: 39697741 Free PMC article. Review.
127 results